Home 2010 July

Monthly Archives: July 2010

ACCORD Eye Study Finds 2 Therapies Slow Diabetic Eye Disease Progression

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

Cashew Seed Extract an Effective Anti-Diabetic

Cashew seed extract shows promise as an effective anti-diabetic, according to a new study.

New Treatment for Crippling Diabetic Charcot Foot

The alarming increase of morbidly obese diabetics is causing more new cases of a debilitating foot deformity called Charcot foot.

Implanted Glucose Sensor Works for More Than 1 Year

Bioengineers have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver.

FDA Statement on Avandia TIDE Trial

GlaxoSmithKline (GSK), the manufacturer of the diabetes drug Avandia (rosiglitazone), has been informed by FDA that the postmarketing trial known as TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) has been placed on partial clinical hold.

Aggressive Control of Cardiac Risk Factors Might Not Benefit All Patients with Diabetes

Report suggests that aggressively pursuing low blood pressure and cholesterol levels may not benefit, and could even harm, some patients with diabetes.

Embryonic Cell and Adult Pig Islet Transplants Cure Diabetes Without Need for Immune Suppression...

In a step toward curing diabetes, scientists at Washington University School of Medicine in St. Louis have alleviated the disease using transplants from both embryonic and adult pigs.

Eye Study Finds 2 Therapies Slow Diabetic Eye Disease Progression

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

Near-Normal Blood Sugar Target Did Not Delay Risk of Organ Damage in People with...

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage.

Type 2 Diabetes Medication Rosiglitazone Associated with Increased Cardiovascular Risks and Death

A new study published by JAMA shows that among patients age 65 years and older, rosiglitazone is associated with an increased risk of stroke, heart failure, and all-cause mortality when compared with pioglitazone.

From the Archive

Other Health News